-
公开(公告)号:US09862689B2
公开(公告)日:2018-01-09
申请号:US15036741
申请日:2014-11-13
Applicant: GENENTECH, INC.
Inventor: Hans Iding , Reinhard Reents , Michelangelo Scalone , Francis Gosselin
IPC: C07D239/70 , C07C269/06 , C07C271/22 , C12P17/16
CPC classification number: C07D239/70 , C07B2200/07 , C07C269/06 , C07C271/22 , C12P17/165
Abstract: The present invention relates to a process for the preparation of a compound of formula (I), wherein R1 is as defined herein, which is useful as an intermediate in the preparation of active pharmaceutical compounds.
-
公开(公告)号:US10858324B2
公开(公告)日:2020-12-08
申请号:US16555842
申请日:2019-08-29
Applicant: GENENTECH, INC.
Inventor: Hans Iding , Reinhard Reents , Michelangelo Scalone , Francis Gosselin
IPC: A61K31/517 , C07D239/70 , C07C269/06 , C07C271/22 , C12P17/16
Abstract: The present invention relates to a process for the preparation of a compound of formula (I) wherein R1 is as defined herein, which is useful as an intermediate in the preparation of active pharmaceutical compounds.
-
公开(公告)号:US10457648B2
公开(公告)日:2019-10-29
申请号:US15514188
申请日:2015-09-25
Applicant: F. HOFFMANN-LA ROCHE AG , GENENTECH, INC.
Inventor: Francis Gosselin , Chong Han , Hans Iding , Reinhard Reents , Scott Savage , Beat Wirz
IPC: C07D239/70 , C07D239/54 , C07D239/42 , C07C253/30 , C07C255/22 , C07B57/00 , C12P41/00 , C07C253/34 , C12N9/78
Abstract: The present disclosure relates to processes for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds, and more particularly relates to processes for preparing (R)-4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d] pyrimidin-4-yl)piperazine and N-protected derivatives thereof, which may be used as an intermediate in the synthesis of Ipatasertib (i.e., (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)-propan-1-one). The present disclosure additionally relates to various compounds that are intermediates employed in these processes.
-
公开(公告)号:US10435378B2
公开(公告)日:2019-10-08
申请号:US15827985
申请日:2017-11-30
Applicant: GENENTECH, INC.
Inventor: Hans Iding , Reinhard Reents , Michelangelo Scalone , Francis Gosselin
IPC: C12P9/00 , C07D239/70 , C07C269/06 , C07C271/22 , C12P17/16
Abstract: The present invention relates to a process for the preparation of a compound of formula (I) wherein R1 is as defined herein, which is useful as an intermediate in the preparation of active pharmaceutical compounds.
-
公开(公告)号:US11780834B2
公开(公告)日:2023-10-10
申请号:US17110607
申请日:2020-12-03
Applicant: Hoffmann-La Roche Inc. , GENENTECH, INC.
Inventor: Cheol Keun Chung , Jie Xu , Hans Iding , Kyle Clagg , Michael Dalziel , Alec Fettes , Francis Gosselin , Ngiap-Kie Lim , Andrew McClory , Haiming Zhang , Paroma Chakravarty , Karthik Nagapudi , Sarah Robinson
IPC: C07D471/04 , C07D403/14
CPC classification number: C07D471/04 , C07D403/14 , C07B2200/13
Abstract: Provided herein are solid forms, salts, and formulations of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol, processes and synthesis thereof, and methods of their use in the treatment of cancer.
-
公开(公告)号:US10954234B2
公开(公告)日:2021-03-23
申请号:US16443515
申请日:2019-06-17
Applicant: Genentech, Inc. , Hoffman-La Roche, Inc.
Inventor: Cheol Keun Chung , Jie Xu , Hans Iding , Kyle Clagg , Michael Dalziel , Alec Fettes , Francis Gosselin , Ngiap-Kie Lim , Andrew McClory , Haiming Zhang , Paroma Chakravarty , Karthik Nagapudi , Sarah Robinson
IPC: C07D471/04 , C07D403/14 , A61P35/00 , A61P35/04
Abstract: Provided herein are solid forms, salts, and formulations of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol, processes and synthesis thereof, and methods of their use in the treatment of cancer.
-
公开(公告)号:US20200062717A1
公开(公告)日:2020-02-27
申请号:US16555842
申请日:2019-08-29
Applicant: GENENTECH, INC.
Inventor: Hans Iding , Reinhard Reents , Michelangelo Scalone , Francis Gosselin
IPC: C07D239/70 , C12P17/16 , C07C271/22 , C07C269/06
Abstract: The present invention relates to a process for the preparation of a compound of formula (I) wherein R1 is as defined herein, which is useful as an intermediate in the preparation of active pharmaceutical compounds.
-
公开(公告)号:US20200010428A1
公开(公告)日:2020-01-09
申请号:US16574933
申请日:2019-09-18
Applicant: F. HOFFMANN-LA ROCHE AG , GENENTECH INC.
Inventor: Francis Gosselin , Chong Han , Hans Iding , Reinhard Reents , Scott Savage , Beat Wirz
IPC: C07D239/70 , C07B57/00 , C07D239/42 , C07D239/54 , C12N9/78 , C12P41/00 , C07C253/30 , C07C253/34 , C07C255/22
Abstract: The present disclosure relates to processes for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds, and more particularly relates to processes for preparing (R)-4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d] pyrimidin-4-yl)piperazine and N-protected derivatives thereof, which may be used as an intermediate in the synthesis of Ipatasertib (i.e., (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)-propan-1-one). The present disclosure additionally relates to various compounds that are intermediates employed in these processes.
-
公开(公告)号:US11066389B2
公开(公告)日:2021-07-20
申请号:US16718602
申请日:2019-12-18
Applicant: Genentech, Inc.
Inventor: Jinguang Lin , Alexandra Chestakova , Wei Gu , Hans Iding , Jing Li , Xin Linghu , Patrik Meier , Chunbo Sha , Jeffrey Stults , Youchu Wang , Haiming Zhang , Jianqian Zhang , Tao Zhang
IPC: C07D401/14 , C07D401/04 , A61P35/00 , A61P25/00 , A61P29/00 , C12P17/16
Abstract: The present invention provides a process for the manufacture of a compound of formula VIIIa and salts forms of VIIIa where Rc is an aryl sulfonic acid
-
公开(公告)号:US20180086722A1
公开(公告)日:2018-03-29
申请号:US15827985
申请日:2017-11-30
Applicant: GENENTECH, INC.
Inventor: Hans Iding , Reinhard Reents , Michelangelo Scalone , Francis Gosselin
IPC: C07D239/70 , C12P17/16 , C07C271/22 , C07C269/06
Abstract: The present invention relates to a process for the preparation of a compound of formula (I) wherein R1 is as defined herein, which is useful as an intermediate in the preparation of active pharmaceutical compounds.
-
-
-
-
-
-
-
-
-